Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
SaleCommon Stock | 13,784 | $82.79 | $1,141,184.25 |
DisclosureSEC source: 0001209191-17-008456 · doc4.xml · nonDerivative · entry 3 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,655 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.73 to $82.81, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Tax withholdingCommon Stock | 17,405 | $83.80 | $1,458,539.00 |
DisclosureSEC source: 0001209191-17-008456 · doc4.xml · nonDerivative · entry 2 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,439 Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionCommon Stock | 30,000 | $22.95 | $688,500.00 |
DisclosureSEC source: 0001209191-17-008456 · doc4.xml · nonDerivative · entry 1 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 24, 2017 23:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014517 · doc4.xml · nonDerivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,966 Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 30,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · derivative · entry 11 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Tax withholdingCommon Stock | 16,216 | $82.29 | $1,334,414.64 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · nonDerivative · entry 5 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,243 Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionCommon Stock | 30,000 | $22.95 | $688,500.00 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · nonDerivative · entry 4 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC |
Hall Charles JGroup President
|
Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 15,536 | $0.00 Strike: $17.65 | $0.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,914 Underlying: Common Stock · 15,536 shares Expires 2019-10-06 F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC |
Hall Charles JGroup President
|
Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 84,464 | $0.00 Strike: $13.21 | $0.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,464 shares Expires 2019-10-06 F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 100,000 | $82.38 | $8,238,430.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.25 to $82.76, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 15,536 | $17.65 | $274,165.35 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 84,464 | $13.21 | $1,115,558.28 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:29 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantStock Appreciation Right · Derivative | 11,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007899 · doc4.xml · derivative · entry 1 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 Underlying: Common Stock · 11,010 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
GrantStock Appreciation Right · Derivative | 11,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007897 · doc4.xml · derivative · entry 7 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 Underlying: Common Stock · 11,010 shares Expires 2027-02-01 F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 6,375 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-007897 · doc4.xml · derivative · entry 6 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,125 Underlying: Common Stock · 6,375 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 6, 2014. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionStock Appreciation Right · Derivative | 12,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-17-007897 · doc4.xml · derivative · entry 5 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Tax withholdingCommon Stock | 9,901 | $81.96 | $811,485.96 |
DisclosureSEC source: 0001209191-17-007897 · doc4.xml · nonDerivative · entry 3 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,185.8654 Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 6,375 | $37.18 | $237,022.50 |
DisclosureSEC source: 0001209191-17-007897 · doc4.xml · nonDerivative · entry 2 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,086.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:27 UTC |
Morgan Sandra L.SVP-Provider Relations
|
Exercise / conversionCommon Stock | 12,500 | $22.95 | $286,875.00 |
DisclosureSEC source: 0001209191-17-007897 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,711.8654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
GrantStock Appreciation Right · Derivative | 11,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007896 · doc4.xml · derivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 Underlying: Common Stock · 11,010 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:26 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
GrantStock Appreciation Right · Derivative | 14,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007894 · doc4.xml · derivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,680 Underlying: Common Stock · 14,680 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:26 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
SaleCommon Stock | 15,901 | $82.00 | $1,303,882.00 |
DisclosureSEC source: 0001209191-17-007894 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,247.0531 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
GrantStock Appreciation Right · Derivative | 11,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · derivative · entry 10 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 Underlying: Common Stock · 11,010 shares Expires 2027-02-01 F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,252 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · derivative · entry 9 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,252 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F5 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,252 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · derivative · entry 8 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,252 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
SaleCommon Stock | 4,504 | $81.93 | $368,990.65 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · nonDerivative · entry 3 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,459 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.92 to $81.931, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionCommon Stock | 2,252 | $15.91 | $35,832.02 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · nonDerivative · entry 2 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
Davis Jana JoustraSVP - Corporate Affairs
|
Exercise / conversionCommon Stock | 2,252 | $10.92 | $24,584.63 |
DisclosureSEC source: 0001209191-17-007893 · doc4.xml · nonDerivative · entry 1 Davis Jana Joustra · CIK 0001513409 · SVP - Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:25 UTC |
YUSPEH ALAN RSVP & Chief Ethics Officer
|
GrantStock Appreciation Right · Derivative | 11,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007892 · doc4.xml · derivative · entry 1 YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 Underlying: Common Stock · 11,010 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:24 UTC |
STEAKLEY JOSEPH NSVP-Internal Audit Services
|
GrantStock Appreciation Right · Derivative | 11,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007890 · doc4.xml · derivative · entry 3 STEAKLEY JOSEPH N · CIK 0001216853 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 Underlying: Common Stock · 11,010 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:23 UTC |
Torres Kathryn A.SVP- Employer&Payer Engagement
|
GrantStock Appreciation Right · Derivative | 14,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007889 · doc4.xml · derivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP- Employer&Payer Engagement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,680 Underlying: Common Stock · 14,680 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:23 UTC | GrantStock Appreciation Right · Derivative | 14,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007888 · doc4.xml · derivative · entry 1 CAMPBELL VICTOR L · CIK 0001216831 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,680 Underlying: Common Stock · 14,680 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
|
| February 01, 2017 Filed Feb 4, 2017 00:22 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantStock Appreciation Right · Derivative | 14,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007887 · doc4.xml · derivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,680 Underlying: Common Stock · 14,680 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:21 UTC |
Paslick P. MartinSVP and CIO
|
GrantStock Appreciation Right · Derivative | 18,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007886 · doc4.xml · derivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,340 Underlying: Common Stock · 18,340 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:20 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantStock Appreciation Right · Derivative | 18,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007885 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,340 Underlying: Common Stock · 18,340 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:20 UTC |
Cuffe Michael S.President-Physician Services
|
GrantStock Appreciation Right · Derivative | 22,930 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007884 · doc4.xml · derivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,930 Underlying: Common Stock · 22,930 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:19 UTC |
STEELE JOHN MSVP - Human Resources
|
GrantStock Appreciation Right · Derivative | 22,010 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007883 · doc4.xml · derivative · entry 1 STEELE JOHN M · CIK 0001269276 · SVP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,010 Underlying: Common Stock · 22,010 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:19 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
GrantStock Appreciation Right · Derivative | 25,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007881 · doc4.xml · derivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,680 Underlying: Common Stock · 25,680 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:18 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantStock Appreciation Right · Derivative | 22,930 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007880 · doc4.xml · derivative · entry 8 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,930 Underlying: Common Stock · 22,930 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
GrantStock Appreciation Right · Derivative | 25,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007878 · doc4.xml · derivative · entry 8 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,680 Underlying: Common Stock · 25,680 shares Expires 2027-02-01 F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,573 | $0.00 Strike: $5.78 | $0.00 |
DisclosureSEC source: 0001209191-17-007878 · doc4.xml · derivative · entry 7 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,854 Underlying: Common Stock · 11,573 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 15, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,427 | $0.00 Strike: $5.78 | $0.00 |
DisclosureSEC source: 0001209191-17-007878 · doc4.xml · derivative · entry 6 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,427 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F5 · derivative.exercise_date: The option vested in equal increments at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 46,055 | $0.00 Strike: $5.78 | $0.00 |
DisclosureSEC source: 0001209191-17-007878 · doc4.xml · derivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,055 shares Expires 2017-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.exercise_date: On November 15, 2007, the reporting person was granted an option to purchase 96,055 shares of common stock, which vest upon achievement of certain predetermined investment return targets. 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of the closing of the initial public offering of the Issuer's securities on March 15, 2011, 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2011 and 1/3 of the option vested as a result of the achievement of certain specified investment return targets as of December 31, 2012. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
SaleCommon Stock | 66,055 | $82.00 | $5,416,510.00 |
DisclosureSEC source: 0001209191-17-007878 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,249.2407 F1 · balance_after: Includes 898.2407 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 66,055 | $5.78 | $382,108.36 |
DisclosureSEC source: 0001209191-17-007878 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,304.2407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 898.2407 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:17 UTC |
Foster Jon MGroup President
|
GrantStock Appreciation Right · Derivative | 27,510 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007877 · doc4.xml · derivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,510 Underlying: Common Stock · 27,510 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:16 UTC |
Hall Charles JGroup President
|
GrantStock Appreciation Right · Derivative | 27,510 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,510 Underlying: Common Stock · 27,510 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:15 UTC |
RUTHERFORD BILL BCFO and EVP
|
GrantStock Appreciation Right · Derivative | 56,850 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007875 · doc4.xml · derivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,850 Underlying: Common Stock · 56,850 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:14 UTC |
HAZEN SAMUEL NPresident & COO
|
GrantStock Appreciation Right · Derivative | 84,360 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007874 · doc4.xml · derivative · entry 6 HAZEN SAMUEL N · CIK 0001216838 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,360 Underlying: Common Stock · 84,360 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:13 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
GrantStock Appreciation Right · Derivative | 183,380 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007873 · doc4.xml · derivative · entry 1 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,380 Underlying: Common Stock · 183,380 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.